• Home

  • Documents

  • 50102987B-OL - Valeant · PDF fileTitle: 50102987B-OL Created Date: 12/3/2013 5:27:23 PM
8

50102987B-OL - Valeant · PDF fileTitle: 50102987B-OL Created Date: 12/3/2013 5:27:23 PM

  • Upload
    lycong

  • View
    224

  • Download
    5

Embed Size (px)

Citation preview

Page 1: 50102987B-OL - Valeant · PDF fileTitle: 50102987B-OL Created Date: 12/3/2013 5:27:23 PM
Page 2: 50102987B-OL - Valeant · PDF fileTitle: 50102987B-OL Created Date: 12/3/2013 5:27:23 PM
Page 3: 50102987B-OL - Valeant · PDF fileTitle: 50102987B-OL Created Date: 12/3/2013 5:27:23 PM
Page 4: 50102987B-OL - Valeant · PDF fileTitle: 50102987B-OL Created Date: 12/3/2013 5:27:23 PM
Page 5: 50102987B-OL - Valeant · PDF fileTitle: 50102987B-OL Created Date: 12/3/2013 5:27:23 PM
Page 6: 50102987B-OL - Valeant · PDF fileTitle: 50102987B-OL Created Date: 12/3/2013 5:27:23 PM
Page 7: 50102987B-OL - Valeant · PDF fileTitle: 50102987B-OL Created Date: 12/3/2013 5:27:23 PM
Page 8: 50102987B-OL - Valeant · PDF fileTitle: 50102987B-OL Created Date: 12/3/2013 5:27:23 PM

v36 1P ol - j-creas.com fileTitle: v36_1P_ol Created Date: 2/15/2016 11:26:29 AM

v36 1P ol - j-creas.com fileTitle: v36_1P_ol Created Date: 2/15/2016 11:26:29 AM

Documents
Valeant pharma case study

Valeant pharma case study

Health & Medicine
SSR銀座デザートメニューP7 OL - mrs · PDF fileTitle: SSR銀座デザートメニューP7_OL

SSR銀座デザートメニューP7 OL - mrs · PDF fileTitle: SSR銀座デザートメニューP7_OL

Documents
Valeant allergan investor presentation final

Valeant allergan investor presentation final

Investor Relations
1 ol - · PDF fileTitle: 1_ol Created Date: 9/7/2012 12:33:30 PM

1 ol - · PDF fileTitle: 1_ol Created Date: 9/7/2012 12:33:30 PM

Documents
(A5) TK1170 manual タOL - · PDF fileTitle (A5) TK1170_manual タOL Created Date: 10/25/2011 1:47:03 PM

(A5) TK1170 manual タOL - · PDF fileTitle (A5) TK1170_manual タOL Created Date: 10/25/2011 1:47:03 PM

Documents
VALEANT | CERAVE

VALEANT | CERAVE

Marketing
Valeant Pharmaceuticals International, Inc. 2016 Annual …/media/Files/V/Valeant-IR/...statements regarding expected future performance of Valeant Pharmaceuticals International, Inc

Valeant Pharmaceuticals International, Inc. 2016 Annual …/media/Files/V/Valeant-IR/...statements regarding expected future performance of Valeant Pharmaceuticals International, Inc

Documents
Valeant Pharmaceutical International, Inc. 2016 J.P. Morgan …/media/Files/V/Valeant-IR/... · 2016. 1. 13. · Valeant Pharmaceutical International, Inc. 2016 J.P. Morgan Healthcare

Valeant Pharmaceutical International, Inc. 2016 J.P. Morgan …/media/Files/V/Valeant-IR/... · 2016. 1. 13. · Valeant Pharmaceutical International, Inc. 2016 J.P. Morgan Healthcare

Documents
bgas vol60 p1-8 ol - · PDF fileTitle: bgas_vol60_p1-8_ol Created Date: 12/8/2017 9:28:47 AM

bgas vol60 p1-8 ol - · PDF fileTitle: bgas_vol60_p1-8_ol Created Date: 12/8/2017 9:28:47 AM

Documents
The Definitive Guide To Valeant Pharmaceuticals (NYSE:VRX) · 2016-04-30 · against Valeant.” The Definitive Guide To Valeant Pharmaceuticals (NYSE:VRX) ... Pharmaceuticals. In

The Definitive Guide To Valeant Pharmaceuticals (NYSE:VRX) · 2016-04-30 · against Valeant.” The Definitive Guide To Valeant Pharmaceuticals (NYSE:VRX) ... Pharmaceuticals. In

Documents
Análisis valeant Final

Análisis valeant Final

Documents
tokyu kanip omote 171020 ol sw2 - · PDF fileTitle: tokyu_kanip_omote_171020_ol_sw2 Created Date: 10/25/2017 10:40:30 PM

tokyu kanip omote 171020 ol sw2 - · PDF fileTitle: tokyu_kanip_omote_171020_ol_sw2 Created Date: 10/25/2017 10:40:30 PM

Documents
Valeant Pharmaceutical International, Inc. 2016 J.P ...ir.valeant.com/~/media/Files/V/Valeant-IR/reports-and... · Valeant Pharmaceutical International, Inc. 2016 J.P ... Company’s

Valeant Pharmaceutical International, Inc. 2016 J.P ...ir.valeant.com/~/media/Files/V/Valeant-IR/reports-and... · Valeant Pharmaceutical International, Inc. 2016 J.P ... Company’s

Documents
Valeant Pharmaceuticals - Pershing Square …assets.pershingsquareholdings.com/2014/09/Investor-Call...Valeant Pharmaceuticals International (VRX) Multinational specialty pharmaceutical

Valeant Pharmaceuticals - Pershing Square …assets.pershingsquareholdings.com/2014/09/Investor-Call...Valeant Pharmaceuticals International (VRX) Multinational specialty pharmaceutical

Documents
K170042 genex総合パンフol - · PDF fileTitle: K170042_genex総合パンフol Author: emi_nishimura Created Date: 12/27/2017 2:30:16 PM

K170042 genex総合パンフol - · PDF fileTitle: K170042_genex総合パンフol Author: emi_nishimura Created Date: 12/27/2017 2:30:16 PM

Documents
Valeant Pharmaceuticals International, Inc. 2012 Annual .../media/Files/V/Valeant-IR/...Valeant Pharmaceuticals International, Inc. 2012 Annual Report Company Overview Valeant Pharmaceuticals

Valeant Pharmaceuticals International, Inc. 2012 Annual .../media/Files/V/Valeant-IR/...Valeant Pharmaceuticals International, Inc. 2012 Annual Report Company Overview Valeant Pharmaceuticals

Documents
Carter PI Allergan Valeant PSCM

Carter PI Allergan Valeant PSCM

Documents
Case Study: Valeant - ValueWalk · 2020-05-23 · We began the year with a 20% weighting in Valeant Pharmaceuticals (NYSE:VRX). Valeant rose by more than 80% through the summer, driving

Case Study: Valeant - ValueWalk · 2020-05-23 · We began the year with a 20% weighting in Valeant Pharmaceuticals (NYSE:VRX). Valeant rose by more than 80% through the summer, driving

Documents
Valeant Pharmaceuticals International, Inc.ir.valeant.com/~/media/Files/V/Valeant-IR/reports-and... · Valeant Pharmaceuticals ... annual or quarterly report and detailed from time

Valeant Pharmaceuticals International, Inc.ir.valeant.com/~/media/Files/V/Valeant-IR/reports-and... · Valeant Pharmaceuticals ... annual or quarterly report and detailed from time

Documents
Valeant Pharmaceuticals International, Inc.ir.valeant.com/~/media/Files/V/Valeant-IR/reports-and-presentations/q1-2016-earnings...Valeant Pharmaceuticals International, Inc. First

Valeant Pharmaceuticals International, Inc.ir.valeant.com/~/media/Files/V/Valeant-IR/reports-and-presentations/q1-2016-earnings...Valeant Pharmaceuticals International, Inc. First

Documents
Valeant Pharmaceuticals International, Inc.ir.valeant.com/~/media/Files/V/Valeant-IR/reports-and...Valeant Pharmaceuticals International, Inc. Q2 2015 Financial Results July 23, 2015

Valeant Pharmaceuticals International, Inc.ir.valeant.com/~/media/Files/V/Valeant-IR/reports-and...Valeant Pharmaceuticals International, Inc. Q2 2015 Financial Results July 23, 2015

Documents
VALEANT PHARMACEUTICALS INTL (VRX) …VALEANT PHARMACEUTICALS INTL (VRX) Earnings Report: Q3 2014 Conference Call Transcript The following VALEANT PHARMACEUTICALS INTL conference call

VALEANT PHARMACEUTICALS INTL (VRX) …VALEANT PHARMACEUTICALS INTL (VRX) Earnings Report: Q3 2014 Conference Call Transcript The following VALEANT PHARMACEUTICALS INTL conference call

Documents
nature hpk Young ol - Hamamatsu Photonics · PDF fileTitle: nature_hpk_Young_ol Created Date: 8/30/2016 8:06:22 PM

nature hpk Young ol - Hamamatsu Photonics · PDF fileTitle: nature_hpk_Young_ol Created Date: 8/30/2016 8:06:22 PM

Documents
Valeant May Lawsuit

Valeant May Lawsuit

Documents
20140528 valeant story draft deckv85

20140528 valeant story draft deckv85

Investor Relations
Valeant Annual Report 2010

Valeant Annual Report 2010

Documents
Valeant Pharmaceuticals Correct Recent Misrepresentations

Valeant Pharmaceuticals Correct Recent Misrepresentations

Investor Relations
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (the “Company”)ir.valeant.com/~/media/Files/V/Valeant-IR/documents/valeant... · i Incorporation number: C0977395 VALEANT PHARMACEUTICALS

VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (the “Company”)ir.valeant.com/~/media/Files/V/Valeant-IR/documents/valeant... · i Incorporation number: C0977395 VALEANT PHARMACEUTICALS

Documents
Investor Call Re Valeant Pharmaceuticals

Investor Call Re Valeant Pharmaceuticals

Documents